DS

Dominic Schmidt

General Partner at Advent Life Sciences

Greater London, England

Invests in

Stages:

Locations:

  • Min Investment:

    $25,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,000,000.00

Work Experience

  • Board Observer

    2024

  • General Partner

    2022

    Investing and building companies in biotech. Venture/Growth.

  • Non Executive Director

    2024

2022

  • Non Executive Director

    2022

  • Non Executive Director

    2022

  • Non Executive Director

    2020 - 2022

  • Non Executive Director

    2020 - 2022

2019 - 2022

  • Non Executive Director

    2019 - 2022

2014 - 2022

  • Partner

    2016 - 2022

    Syncona is a leading FTSE 250 company focused on investing in and building global leaders in life science.

  • Partner

    2014 - 2016

    Syncona operates as an evergreen investment company, taking an active role in identifying, supporting and developing technologies with the potential to significantly impact the healthcare market of the future. Syncona is an investor that can take the long view when necessary, able to concentrate investment into opportunities as technology is validated.

  • Non Executive Director and Board Observer

    2019 - 2022